108 related articles for article (PubMed ID: 11966191)
1. The process of drug development.
Burgess G
Surviv News (Atlanta Ga); 2002 Mar; ():18. PubMed ID: 11966191
[No Abstract] [Full Text] [Related]
2. On approval.
Huff B
GMHC Treat Issues; 2001 Oct; 15(10):5-8. PubMed ID: 11727570
[No Abstract] [Full Text] [Related]
3. T-1249 development hits a snag.
AIDS Clin Care; 2004 Feb; 16(2):15. PubMed ID: 15032178
[No Abstract] [Full Text] [Related]
4. Drug development research: the process.
Sataloff RT
Ear Nose Throat J; 2008 Aug; 87(8):420-2. PubMed ID: 18712686
[No Abstract] [Full Text] [Related]
5. How pharmacogenomics will impact the federal regulation of clinical trials and the new drug approval process.
Binzak BA
Food Drug Law J; 2003; 58(1):103-27. PubMed ID: 12739592
[No Abstract] [Full Text] [Related]
6. The United States Food and Drug Administration and the end of antibiotics.
Shlaes DM; Moellering RC
Clin Infect Dis; 2002 Feb; 34(3):420-2. PubMed ID: 11774094
[No Abstract] [Full Text] [Related]
7. An overview of the drug approval process.
Martinez LJ
Res Initiat Treat Action; 2002; 8(1):11-7. PubMed ID: 12489521
[No Abstract] [Full Text] [Related]
8. FDA notifications. New guidance assists HIV drug development. Changes affect approvals for antiretroviral drugs.
AIDS Alert; 2003 Jan; 18(1):10-1. PubMed ID: 12541998
[TBL] [Abstract][Full Text] [Related]
9. The decreased number of new drug approvals (NDAs) has been a topic of considerable debate over the past decade. Preface.
Enna SJ; Williams M
Adv Pharmacol; 2009; 57():xi-ii. PubMed ID: 19945649
[No Abstract] [Full Text] [Related]
10. Promoting, improving and accelerating the drug development and approval processes.
Graul AI
Drug News Perspect; 2009; 22(1):30-8. PubMed ID: 19209297
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials performed for the new drug approval process in the United States: standard methods and alternative methods.
Browne TR
Epilepsy Res Suppl; 1993; 10():31-44. PubMed ID: 8251105
[No Abstract] [Full Text] [Related]
12. HIV drugs. FDA new drug approval rate lowest in 10 years.
AIDS Policy Law; 2007 Jan; 22(2):5. PubMed ID: 17323437
[No Abstract] [Full Text] [Related]
13. FDA notifications. Tentative approval granted for combo antiretroviral drug.
AIDS Alert; 2007 Oct; 22(10):117-8. PubMed ID: 18416009
[No Abstract] [Full Text] [Related]
14. The Food and Drug Administration's use of postmarketing (Phase IV) study requirements: exception to the rule?
Steenburg C
Food Drug Law J; 2006; 61(2):295-383. PubMed ID: 16903034
[No Abstract] [Full Text] [Related]
15. Advances in cardiovascular pharmacology: protocol design and methodology--the US regulatory process.
Somberg JC; Borer JS
Am J Ther; 1999 May; 6(3):175-8. PubMed ID: 10423661
[No Abstract] [Full Text] [Related]
16. Opinion paper. Resistance to new anti-HIV agents: problems in the pathway of drug registration.
Dalmau D; Klimkait T; Telenti A
Antivir Ther; 2005; 10(7):867-72. PubMed ID: 16312184
[TBL] [Abstract][Full Text] [Related]
17. FDA regulations. FDA shuts down sale of unregulated HIV drug.
AIDS Policy Law; 2004 Sep; 19(18):8. PubMed ID: 18680858
[No Abstract] [Full Text] [Related]
18. The FDA's drug review process: ensuring drugs are safe and effective.
Meadows M
FDA Consum; 2002; 36(4):19-24. PubMed ID: 12184298
[No Abstract] [Full Text] [Related]
19. Science and regulatory rituals associated with the drug development process.
Versteegh LR
Food Drug Law J; 1997; 52(2):155-61. PubMed ID: 10557552
[No Abstract] [Full Text] [Related]
20. Cancer drug approval in the United States, Europe, and Japan.
Milsted RA
Adv Cancer Res; 2007; 96():371-91. PubMed ID: 17161686
[No Abstract] [Full Text] [Related]
[Next] [New Search]
